Program Description

This private business development meeting will include a complete analysis of the Global Aesthetic Market and a five year forecast, provided by Michael Moretti, president of Medical Insight, Inc., the leading market research firm specializing in aesthetic medicine.

Top executives from leading companies in the industry will present their view of the market as well as a preview of their product pipelines. In addition, several new technology companies will be featured on this highly informative and forward-looking half-day program.

Designed specifically for business development executives, investors and analysts, this annual Forum provides a highly condensed review of the aesthetic market and an advanced look at new business opportunities.

Invited VIP Speakers

• Gilles Bos, CEO, Anteis
• Dan Browne, Co-Founder, President & CEO, Revance Therapeutics
• Clint Carnell, President & CEO, myoscience
• Dennis Condon, CEO, Merz Aesthetics
• Shimon Eckhouse, Chairman, Syneron
• Robert Grant, Chairman and Managing Partner, Strathspey Crown
• Matthew Likens, President and CEO, Ulthera, Inc.
• Keith Leonard, President, Kythera Biopharmaceuticals
• George Mahaffey, CEO, Lithera, Inc.
• David Moatazedi, Senior Director of Marketing, Allergan Medical
• Andy Pickett, Ph.D., B.Sc. Founder & Director, Toxin Science Ltd.
• Anna Tenstam Lundvall, CCO, Contura International
• Darell Zoromski, CEO, Miramar Labs

Who should attend:

• Company CEO's and marketing executives
• Business development managers
• Industry analysts
• Investors and entrepreneurs
• Journalists covering the health and beauty sector

Disclaimer: This event is a private industry executive meeting with no affiliation to the American Academy of Dermatology.

Physician members of the American Academy of Dermatology are not permitted to attend this private industry event.